Psoriatic Arthritis Resource Center

Golimumab, ustekinumab

Ustekinumab Versus Other Biologics in Psoriatic Disease: Which Medications Increase Risk for Infection?

In a recent study, researchers compared ustekinumab versus other biologics and apremilast for risk of serious infection requiring hospitalization among patients with psoriasis (PsO)...
psoriasis, cancer

Patient Characteristics at Diagnosis May Predict 10-Year Psoriasis Disease Course

Early identification of certain patient factors may predict long-term outcomes in psoriasis, according to a study. Between 2001 and 2005, patients were enrolled in the...
Golimumab, ustekinumab

Golimumab Treatment Retention Comparison: RA, AxSpA, and PsA

A study retrospectively compared rates of treatment retention with golimumab among patients with rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA), and psoriatic arthritis (PsA). “Retention of...
Tofacitinib Under Review for Heart-related Issues, Cancer in Canada Months after FDA Announcement

Tofacitinib Under Review for Heart-related Issues, Cancer in Canada Months after FDA Announcement

Health Canada is conducting a safety review into tofacitinib following reports that the drug may be associated with serious heart-related issues and cancer. Tofacitinib, manufactured...
therapies, tocilizumab, rheum, RA, keenan, autoimmune, tofacitinib, telemedicine, covid-19, Hydroxychloroquine, Secukinumab, interview, rheumatologists, rheumatologist, arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: Interview with Dr. Keenan, Rixutimab Ups Severe COVID-19 Risk, PsA Drug Comparison

This week in the DocWire News rheumatology section, I interviewed Robert Keenan, MD, an adjunct associate professor at Duke University School of Medicine, Division...
Adalimumab, Upadacitinib Effective in RA Patients with Inadequate Methotrexate Response

Upadacitinib versus Adalimumab: How Do These Arthritis Drugs Compare?

A higher dose of upadacitinib was superior to adalimumab in patients with psoriatic arthritis, according to a study, but outcomes did not largely differ...
drug, vaccine, lupus, cbd, Psoriasis, psoriatic, hydroxychloroquine, RA, ACR, vitamin, vitamins, Rheum Round-up: Interviews with Authors of ‘Untold Stories’ of Female Surgeons, and more

Rheum Round-up: Psoriatic Arthritis Medication Research, Hip Fracture Survival

Guselkumab Safe, Effective in Biologic-naïve Patients with Psoriatic Arthritis Guselkumab was a safe and effective treatment for biologic-naïve patients with psoriatic arthritis (PsA), according to...

Curated Journal Reading List